Source: Υπουργείο Υγείας (CY) Revision Year: 2015 Publisher: MEDOCHEMIE LTD, 1-10 Constantinoupoleos street, 3011 Limassol, Cyprus
Aponil 100 mg tablets.
| Pharmaceutical Form |
|---|
|
Tablet. Light yellow, round flat, scored, with diameter of 10.5 mm. The tablet can be divided into equal doses. |
Each tablet contains 100 mg nimesulide.
Excipient with known effect: lactose monohydrate.
Each 100 mg tablet contains 153.7 mg lactose.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Nimesulide |
Nimesulide is a non-steroidal anti-inflammatory drug with analgesic and antipyretic properties which acts as an inhibitor of prostaglandin synthesis enzyme cyclo-oxygenase. Cyclo-oxygenase produces prostaglandins, some of them being implicated in the development and maintenance of inflammation. |
| List of Excipients |
|---|
|
Aponil also contains lactose monohydrate, cellulose microcrystalline, docusate sodium, sodium starch glycolate, hydroxypropyl cellulose, hydrogenated vegetable oil, magnesium stearate. |
PVC-Aluminum blisters of 10, 20 and 30 tablets.
Not all pack sizes may be marketed.
MEDOCHEMIE LTD, 1-10 Constantinoupoleos street, 3011 Limassol, Cyprus
17417
Date of first authorisation: 11/11/1997
Date of latest renewal: 20/09/2010
| Drug | Countries | |
|---|---|---|
| APONIL | Cyprus, Hong Kong, Lithuania, Romania |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
